Altamira Therapeutics Ltd.: xbrl:AdjustmentsForDecreaseIncreaseInPrepaidExpenses

Value{"amount": 255449, "currency": "USD"}
Period2024-01-01 – 2024-06-30
Statuscurrent
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-25-082071
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/ba2d6202-2956-467d-b70b-1e4036d7deea

History